# Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation

> **NCT07095959** · NA · RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 340 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **PROCEDURE:** vein of Marshall ethanol infusion
- **PROCEDURE:** PVI using pulsed field ablation

## Key facts

- **NCT ID:** NCT07095959
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2027-07-10
- **Final completion:** 2027-09-01
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07095959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07095959, "Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07095959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*